siRNA therapeutics for metabolic disorder(SanegeneBio Inc)

N/A

Report date: 2025/01/26 17:05:18
NME

Base Information

Drug NamesiRNA therapeutics for metabolic disorder(SanegeneBio Inc)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanegene Bio USA Inc
China Registration ClassN/A

Develop Information

Active CompaniesSanegene Bio USA Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A